KZR - Kezar Life Sciences GAAP EPS of -$0.34 in-line August, 11 2023 04:07 AM Kezar Life Sciences Inc. 2023-08-11 04:07:07 ET Kezar Life Sciences press release ( NASDAQ: KZR ): Q2 GAAP EPS of -$0.34 in-line. Cash, cash equivalents and marketable securities totaled $236.6 million as of June 30, 2023, compared to $276.6 million as of December 31, 2022. For further details see: Kezar Life Sciences GAAP EPS of -$0.34 in-line